Imvax: Personalized Immunotherapy for Glioblastoma Patients
** Sponsored by Imvax. This content is not an endorsement from the ABTA.** Imvax is a pioneering clinical biotechnology company developing personalized cancer treatments specifically designed for glioblastoma (GBM) patients.